vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and REPUBLIC BANCORP INC (RBCAA). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $94.3M, roughly 1.1× REPUBLIC BANCORP INC). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 5.3%). REPUBLIC BANCORP INC produced more free cash flow last quarter ($161.1M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -11.5%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Republic Bancorp Inc. (Kentucky) is a U.S. regional banking holding company that provides a full range of retail and commercial banking services, including personal deposit accounts, consumer loans, business financing, mortgage products, and wealth management solutions. It mainly serves individual consumers and small to medium-sized enterprises in Kentucky and adjacent U.S. states.

IMCR vs RBCAA — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.1× larger
IMCR
$104.5M
$94.3M
RBCAA
Growing faster (revenue YoY)
IMCR
IMCR
+19.0% gap
IMCR
24.3%
5.3%
RBCAA
More free cash flow
RBCAA
RBCAA
$196.6M more FCF
RBCAA
$161.1M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
-11.5%
RBCAA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
RBCAA
RBCAA
Revenue
$104.5M
$94.3M
Net Profit
$22.8M
Gross Margin
97.4%
Operating Margin
-18.8%
29.3%
Net Margin
24.2%
Revenue YoY
24.3%
5.3%
Net Profit YoY
20.0%
EPS (diluted)
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$104.5M
$94.3M
Q3 25
$103.7M
$93.5M
Q2 25
$98.0M
$93.8M
Q1 25
$93.9M
$135.8M
Q4 24
$84.1M
$89.5M
Q3 24
$80.2M
$88.1M
Q2 24
$75.4M
$86.9M
Q1 24
$70.5M
$120.3M
Net Profit
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$22.8M
Q3 25
$-177.0K
$29.7M
Q2 25
$-10.3M
$31.5M
Q1 25
$5.0M
$47.3M
Q4 24
$19.0M
Q3 24
$8.7M
$26.5M
Q2 24
$-11.6M
$25.2M
Q1 24
$-24.4M
$30.6M
Gross Margin
IMCR
IMCR
RBCAA
RBCAA
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
RBCAA
RBCAA
Q4 25
-18.8%
29.3%
Q3 25
-6.9%
40.4%
Q2 25
-15.2%
43.0%
Q1 25
-3.9%
44.1%
Q4 24
-23.1%
25.8%
Q3 24
-10.6%
38.4%
Q2 24
-21.2%
37.0%
Q1 24
-37.6%
32.2%
Net Margin
IMCR
IMCR
RBCAA
RBCAA
Q4 25
24.2%
Q3 25
-0.2%
31.8%
Q2 25
-10.5%
33.5%
Q1 25
5.4%
34.8%
Q4 24
21.2%
Q3 24
10.9%
30.1%
Q2 24
-15.4%
29.0%
Q1 24
-34.7%
25.4%
EPS (diluted)
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$-0.61
Q3 25
$0.00
Q2 25
$-0.20
Q1 25
$0.10
Q4 24
$-0.47
Q3 24
$0.17
Q2 24
$-0.23
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
RBCAA
RBCAA
Cash + ST InvestmentsLiquidity on hand
$864.2M
$220.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$1.1B
Total Assets
$1.1B
$7.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$864.2M
$220.0M
Q3 25
$892.4M
$484.2M
Q2 25
$882.8M
$484.8M
Q1 25
$837.0M
$793.0M
Q4 24
$820.4M
$432.2M
Q3 24
$901.3M
$530.9M
Q2 24
$859.6M
$400.1M
Q1 24
$832.8M
$546.4M
Total Debt
IMCR
IMCR
RBCAA
RBCAA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$381.0M
$1.1B
Q3 25
$396.6M
$1.1B
Q2 25
$388.5M
$1.1B
Q1 25
$378.5M
$1.0B
Q4 24
$360.7M
$992.0M
Q3 24
$377.8M
$979.7M
Q2 24
$359.1M
$955.4M
Q1 24
$359.5M
$935.6M
Total Assets
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$1.1B
$7.0B
Q3 25
$1.1B
$7.0B
Q2 25
$1.1B
$7.0B
Q1 25
$1.0B
$7.1B
Q4 24
$1.0B
$6.8B
Q3 24
$1.1B
$6.7B
Q2 24
$1.0B
$6.6B
Q1 24
$994.0M
$6.9B
Debt / Equity
IMCR
IMCR
RBCAA
RBCAA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
RBCAA
RBCAA
Operating Cash FlowLast quarter
$-32.7M
$168.2M
Free Cash FlowOCF − Capex
$-35.5M
$161.1M
FCF MarginFCF / Revenue
-34.0%
170.9%
Capex IntensityCapex / Revenue
2.8%
7.5%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$288.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$-32.7M
$168.2M
Q3 25
$-4.5M
$33.3M
Q2 25
$26.0M
$8.4M
Q1 25
$435.0K
$93.2M
Q4 24
$-14.0M
$149.0M
Q3 24
$21.1M
$51.3M
Q2 24
$23.5M
$4.0M
Q1 24
$-4.6M
$71.2M
Free Cash Flow
IMCR
IMCR
RBCAA
RBCAA
Q4 25
$-35.5M
$161.1M
Q3 25
$-5.2M
$30.8M
Q2 25
$25.6M
$5.2M
Q1 25
$137.0K
$91.6M
Q4 24
$-17.5M
$143.2M
Q3 24
$20.3M
$49.8M
Q2 24
$23.1M
$2.7M
Q1 24
$-5.0M
$69.1M
FCF Margin
IMCR
IMCR
RBCAA
RBCAA
Q4 25
-34.0%
170.9%
Q3 25
-5.0%
32.9%
Q2 25
26.1%
5.5%
Q1 25
0.1%
67.4%
Q4 24
-20.9%
160.0%
Q3 24
25.3%
56.5%
Q2 24
30.7%
3.1%
Q1 24
-7.1%
57.5%
Capex Intensity
IMCR
IMCR
RBCAA
RBCAA
Q4 25
2.8%
7.5%
Q3 25
0.7%
2.6%
Q2 25
0.4%
3.5%
Q1 25
0.3%
1.2%
Q4 24
4.3%
6.5%
Q3 24
1.0%
1.7%
Q2 24
0.4%
1.5%
Q1 24
0.6%
1.7%
Cash Conversion
IMCR
IMCR
RBCAA
RBCAA
Q4 25
7.37×
Q3 25
1.12×
Q2 25
0.27×
Q1 25
0.09×
1.97×
Q4 24
7.84×
Q3 24
2.42×
1.93×
Q2 24
0.16×
Q1 24
2.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons